Nippon Life Global Investors Americas Inc. raised its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 117.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,970 shares of the company's stock after buying an additional 5,380 shares during the quarter. Nippon Life Global Investors Americas Inc.'s holdings in Procter & Gamble were worth $1,699,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently added to or reduced their stakes in PG. Nuveen LLC acquired a new position in Procter & Gamble in the first quarter valued at about $1,954,941,000. GAMMA Investing LLC lifted its stake in Procter & Gamble by 20,758.5% in the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock valued at $1,355,087,000 after buying an additional 7,913,335 shares during the period. Price T Rowe Associates Inc. MD raised its position in shares of Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the period. Invesco Ltd. raised its position in shares of Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Procter & Gamble by 15.8% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock worth $2,728,430,000 after purchasing an additional 2,224,912 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Stock Down 0.6%
PG stock traded down $0.90 during mid-day trading on Monday, reaching $159.12. The company had a trading volume of 7,175,827 shares, compared to its average volume of 6,145,017. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The stock has a 50 day simple moving average of $156.41 and a two-hundred day simple moving average of $162.14. The company has a market capitalization of $372.42 billion, a price-to-earnings ratio of 24.44, a PEG ratio of 4.22 and a beta of 0.36. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business's revenue was up 1.7% compared to the same quarter last year. During the same period last year, the company earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is currently 64.98%.
Insider Transactions at Procter & Gamble
In other news, CFO Andre Schulten sold 11,638 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the transaction, the chief financial officer directly owned 52,642 shares in the company, valued at approximately $8,279,007.34. The trade was a 18.11% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Shailesh Jejurikar sold 13,039 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $2,050,643.53. Following the transaction, the chief operating officer owned 28,036 shares of the company's stock, valued at $4,409,221.72. This represents a 31.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 120,181 shares of company stock valued at $18,918,012. 0.20% of the stock is owned by insiders.
Analyst Ratings Changes
PG has been the topic of a number of research analyst reports. Wells Fargo & Company dropped their price target on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. BNP Paribas reaffirmed an "outperform" rating and set a $177.00 price target on shares of Procter & Gamble in a research report on Friday, August 15th. Evercore ISI reaffirmed an "in-line" rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Finally, UBS Group set a $180.00 price target on Procter & Gamble and gave the stock a "buy" rating in a research report on Wednesday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $175.12.
Get Our Latest Stock Analysis on Procter & Gamble
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report